These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6973627)

  • 1. The influence of vasopressin on hypothalamic corticotrophin releasing activity in rats with inherited diabetes insipidus.
    Buckingham JC
    J Physiol; 1981 Mar; 312():9-16. PubMed ID: 6973627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of hypothalamic corticotropin releasing activity by vasopressin: studies in the Brattleboro rat.
    Buckingham JC
    Ann N Y Acad Sci; 1982; 394():580-6. PubMed ID: 6295234
    [No Abstract]   [Full Text] [Related]  

  • 3. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotrophin releasing activity in extracts of the stalk median eminence of Brattleboro rats.
    Gillies G; Lowry PJ
    J Endocrinol; 1980 Jan; 84(1):65-73. PubMed ID: 6987324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro.
    Gillies G; Puri A; Hodgkinson S; Lowry PJ
    J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus.
    Buckingham JC; Leach JH
    J Physiol; 1980 Aug; 305():397-404. PubMed ID: 6255146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami.
    Ackland JF; Ratter SJ; Bourne GL; Rees LH
    J Endocrinol; 1986 Feb; 108(2):171-80. PubMed ID: 3485168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors.
    Buckingham JC; Hodges JR
    J Endocrinol; 1977 Feb; 72(2):187-93. PubMed ID: 191557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High, vasopressin-reversible, immunoreactive somatostatin in specific hypothalamic nuclei of rats with diabetes insipidus (Brattleboro rats).
    Saavedra JM; Rougeot C; Chevillard C; Dray F
    Brain Res; 1983 Oct; 277(1):23-30. PubMed ID: 6139144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
    Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat.
    Bodnar RJ; Wallace MM; Kordower JH; Nilaver G; Cort J; Zimmerman EA
    Ann N Y Acad Sci; 1982; 394():735-9. PubMed ID: 6960791
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the corticotrophin releasing activity of a posterior pituitary extract.
    Kirkland SC; Ellison ML
    J Endocrinol; 1981 Jun; 89(3):423-9. PubMed ID: 6265579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine corticotropin-releasing factor and vasopressin: antibody-quenching studies on hypothalamic extracts of normal and Brattleboro rats.
    Linton EA; Gillies GE; Lowry PJ
    Endocrinology; 1983 Nov; 113(5):1878-83. PubMed ID: 6605243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin.
    Patchev VK; Racké K; Almeida OF
    Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
    Hillhouse EW; Milton NG
    J Endocrinol; 1989 Sep; 122(3):719-23. PubMed ID: 2809479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK; Kalogeras KT; Zelazowski P; Wilder RL; Chrousos GP
    Endocrinology; 1992 Sep; 131(3):1453-7. PubMed ID: 1505475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
    Cai L; Li R; Zhou JN
    Brain Res; 2015 Mar; 1601():1-7. PubMed ID: 25578258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS; Brooks AN
    J Dev Physiol; 1992 May; 17(5):241-6. PubMed ID: 1281183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copeptin as a marker of an altered CRH axis in pituitary disease.
    Lewandowski KC; Lewiński A; Skowrońska-Jóźwiak E; Malicka K; Horzelski W; Brabant G
    Endocrine; 2017 Sep; 57(3):474-480. PubMed ID: 28795329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.